Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations

被引:12
作者
Pakhrin, Pukar Singh [1 ]
Xie, Yongzhi [1 ]
Hu, Zhengmao [2 ]
Li, Xiaobo [1 ]
Liu, Lei [1 ]
Huang, Shunxiang [1 ]
Wang, Binghao [1 ]
Yang, Zihan [1 ]
Zhang, Jiejun [1 ]
Liu, Xin [1 ]
Xia, Kun [2 ]
Tang, Beisha [3 ]
Zhang, Ruxu [1 ]
机构
[1] Cent S Univ, Dept Neurol, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China
[2] Cent S Univ, Sch Life Sci, Ctr Med Genet, Changsha 410008, Hunan, Peoples R China
[3] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha 410008, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
CMT; GDAP1; Genotype; Phenotype; AR-CMT2K; AD-CMT2K; DIFFERENTIATION-ASSOCIATED PROTEIN-1; PERONEAL MUSCULAR-ATROPHY; VOCAL CORD; CLINICAL-FEATURES; DISEASE FREQUENCY; FOUNDER MUTATION; GENETIC SUBTYPES; DOMINANT FORM; 4A DISEASE; NEUROPATHY;
D O I
10.1007/s00415-018-8743-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K). Over 80 different mutations have been identified so far. With the use of Sanger sequencing and Next Generation Sequencing (NGS) technologies, we screened a cohort of 306 unrelated Chinese CMT patients and identified 8 variants in the GDAP1 gene in 4 families, 5 of which were novel (R41H, N201Kfs*5, Q38X, V215I and Q38R). Application of Bioinformatics tool and classification according to the American College of Medical Genetics (ACMG) predicted them of being likely pathogenic with the exception of one variant of uncertain significance (VUS). In addition, we detected the presence of a single heterozygous variant of uncertain significance H256R in one additional family from the CMT cohorts. We found a GDAP1 prevalence rate of 1.63% (5/306). Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance. Electro-physiologic studies revealed an axonal type of neuropathy (AR-CMT2K and AD-CMT2K) in all affected individuals. Clinical characteristics and findings in our study demonstrated that the recessive form presented earlier in life and exhibited severe symptoms and rapid evolution compared to the dominant form. We observed a marked intra-familial variability within the AD family in terms of age at disease onset, symptom severity and clinical progression. Our study expands the mutational spectrum of GDAP1-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of neuropathy in CMT disease associated with GDAP1. We highlight the clinical characteristics associated with these genotypes and describe the relative frequency of GDAP1 variants amongst the Chinese population.
引用
收藏
页码:637 / 646
页数:10
相关论文
共 46 条
[1]   Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan [J].
Abe, Akiko ;
Numakura, Chikahiko ;
Kijima, Kazuki ;
Hayashi, Makiko ;
Hashimoto, Taeko ;
Hayasaka, Kiyoshi .
JOURNAL OF HUMAN GENETICS, 2011, 56 (05) :364-368
[2]   Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease [J].
Ammar, N ;
Nelis, E ;
Merlini, L ;
Barisic, N ;
Amouri, R ;
Ceuterick, C ;
Martin, JJ ;
Timmerman, V ;
Hentati, F ;
De Jonghe, P .
NEUROMUSCULAR DISORDERS, 2003, 13 (09) :720-728
[3]   Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland [J].
Auranen, Mari ;
Ylikallio, Emil ;
Toppila, Jussi ;
Somer, Mirja ;
Kiuru-Enari, Sari ;
Tyynismaa, Henna .
NEUROGENETICS, 2013, 14 (02) :123-132
[4]   Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene [J].
Azzedine, H ;
Ruberg, M ;
Ente, D ;
Gilardeau, C ;
Périé, S ;
Wechsler, B ;
Brice, A ;
LeGuern, E ;
Dubourg, O .
NEUROMUSCULAR DISORDERS, 2003, 13 (04) :341-346
[5]   GDAP1 mutations in Czech families with early-onset CMT [J].
Barankova, L. ;
Vyhnalkova, E. ;
Zuechner, S. ;
Mazanec, R. ;
Sakmaryova, I. ;
Vondracek, P. ;
Merlini, L. ;
Bojar, M. ;
Nelis, E. ;
De Jonghe, P. ;
Seeman, P. .
NEUROMUSCULAR DISORDERS, 2007, 17 (06) :482-489
[6]   Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21 [J].
Baxter, RV ;
Ben Othmane, K ;
Rochelle, JM ;
Stajich, JE ;
Hulette, C ;
Dew-Knight, S ;
Hentati, F ;
Ben Hamida, M ;
Bel, S ;
Stenger, JE ;
Gilbert, JR ;
Pericak-Vance, MA ;
Vance, JM .
NATURE GENETICS, 2002, 30 (01) :21-22
[7]   CMT4A:: Identification of a Hispanic GDAP1 founder mutation [J].
Boerkoel, CF ;
Takashima, H ;
Nakagawa, M ;
Izumo, S ;
Armstrong, D ;
Butler, I ;
Mancias, P ;
Papasozomenos, SCH ;
Stern, LZ ;
Lupski, JR .
ANNALS OF NEUROLOGY, 2003, 53 (03) :400-405
[8]   A locus-specific database for mutations in GDAP1 allows analysis of genotype-phenotype correlations in Charcot-Marie-Tooth diseases type 4A and 2K [J].
Cassereau, Julien ;
Chevrollier, Arnaud ;
Bonneau, Dominique ;
Verny, Christophe ;
Procaccio, Vincent ;
Reynier, Pascal ;
Ferre, Marc .
ORPHANET JOURNAL OF RARE DISEASES, 2011, 6
[9]   Mitochondrial dysfunction and pathophysiology of Charcot-Marie-Tooth disease involving GDAP1 mutations [J].
Cassereau, Julien ;
Chevrollier, Arnaud ;
Gueguen, Naig ;
Desquiret, Valerie ;
Verny, Christophe ;
Nicolas, Guillaume ;
Dubas, Frederic ;
Amati-Bonneau, Patrizia ;
Reynier, Pascal ;
Bonneau, Dominique ;
Procaccio, Vincent .
EXPERIMENTAL NEUROLOGY, 2011, 227 (01) :31-41
[10]   Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K) [J].
Cassereau, Julien ;
Chevrollier, Arnaud ;
Gueguen, Naig ;
Malinge, Marie-Claire ;
Letournel, Franck ;
Nicolas, Guillaume ;
Richard, Laurence ;
Ferre, Marc ;
Verny, Christophe ;
Dubas, Frederic ;
Procaccio, Vincent ;
Amati-Bonneau, Patrizia ;
Bonneau, Dominique ;
Reynier, Pascal .
NEUROGENETICS, 2009, 10 (02) :145-150